Form 4: MAIA Biotechnology Director Louie Ngar Yee Acquires Shares and Warrants

Director Louie Ngar Yee purchased 19,665 shares of common stock and warrants of MAIA Biotechnology, Inc. on April 25, 2024.

Summary

• On April 25, 2024, Louie Ngar Yee, a director of MAIA Biotechnology, Inc., acquired 19,665 shares of common stock at $2.03 per share.
• The director also acquired warrants to purchase 19,665 shares of common stock at an exercise price of $2.26.
• These transactions were made pursuant to a Securities Purchase Agreement dated April 22, 2024.
• Following the reported transaction, Louie Ngar Yee directly owns 1,167,189 shares of MAIA Biotechnology, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a director suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in the biotechnology industry. Monitoring such transactions can provide insights into management's sentiment about the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates